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The crowded conditions that exist in many of the
world's jails and prisons create an ideal envi-
ronment for the transmission of contagious dis-
eases. Restrictions on the availability of clean
laundry, soap, water, condoms and needle
exchange increase the probability that infec-
tious diseases will be transmitted from one per-
son to another. Furthermore, the transient sta-
tus of inmates who are frequently moved from
one location to another can complicate the diag-
nosis of infection, recognition of an outbreak,
performance of a contact investigation, interrup-
tion of ongoing transmission,and eradication of
disease.
Infection Control Program
and Infection Control
Committee
All correctional facilities should have an infec-
tion control program. Typical activities to pre-
vent and control communicable diseases (CD)
include:
w Educating staff and inmates, 
w Establishing a written exposure control plan
that minimizes the potential for employee
exposure to blood borne pathogens,
w Encouraging staff and inmates to be vacci-
nated, 
w Monitoring the incidence of selected CD
among staff and inmates,
w Ensuring that inmates receive prompt and
appropriate treatment and monitoring adher-
ence,
w Establishing and enforcing isolation policies, 
w Ensuring that personal protective equipment
is available to and utilized by staff,
w Evaluating and making available sharps
devices that are least likely to cause injury,
w Overseeing an effective post-exposure pro-
gram, and
w Ensuring that reports are completed and
submitted as required by local, state and feder-
al laws and regulations.
The infection control program should be man-
aged by an infection control committee that
includes physicians, representatives from cus-
tody, administration, nursing, dental, house-
keeping, food services, unions if applicable, and
other clinical areas at the facility such as labo-
ratory, surgery, dialysis, respiratory therapy, and
physical therapy. Although smaller facilities may
not require the complex program necessary in a
facility with a large medical mission, the basic
lements remain the same. 
Personal Protective
Equipment (PPE)
Personal protective equipment (PPE) applies to
clothing and equipment intended to protect
employees from coming into contact with blood,
other body fluids and contaminated air. PPE
includes masks, respirators, gloves, goggles,
face shields, gowns, hoods, and foot coverings.
PPE should be readily accessible in all patient
care areas, housing units, transportation vehi-
cles, the laundry, and anywhere that employees
are likely to come into contact with inmates.
PPE should be inventoried on a regular basis
and replaced as needed. Staff should be
encouraged to carry gloves with them at all
times so that they are prepared to protect them-
selves when responding to altercations, self
mutilators, suicide attempts, and other medical
emergencies. Making gloves available at areas
where custody staff sign in each day may facili-
tate their use of PPE by correctional employees. 
Personal respiratory protection should be used
by staff whenever they enter a room in which a
person with known or suspected pathogen that
can be transmitted via the air. Those who are in
the area of cough- inducing procedures should
also wear respiratory protection. Although no
respiratory protective device will be 100% pro-
tective, when used consistently and correctly,
respirators are highly reliable in the prevention
of acquisition of respiratory pathogens.
Respirators should be rated at least N-95 effi-
ciency, be able to be fit-tested, and be available
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INFECTION CONTROL IN THE CORRECTIONAL SETTING
Joseph Bick,* MD
in several sizes to accommodate different
facial sizes and characteristics.
Blood Borne Pathogen
(BBP) Exposures
Needlestick and other sharps injuries can
occur during a variety of activities, includ-
ing:
w Replacing the cap on used needles, 
w Disposing of needles,
w Administering injections, 
w Drawing blood, 
w Suturing,
w Passing sharps devices from one per-
son to another,
w Handling trash and dirty linens, 
w Intentional use of sharps as a weapon,
and
w Cell search or body search.
Inmates are at risk for BBP exposures dur-
ing injection drug use, tattooing, fights, and
unprotected sexual activity. Correctional
employees also face a rather unique risk of
being intentionally exposed to blood borne
pathogens by inmates who throw body flu-
ids at them (known as "gassing" or "chunk-
ing"). 
Decreasing the risk of BBP exposure can
be accomplished by vaccination of at-risk
staff and inmates, education concerning
the appropriate use of PPE, harm reduction
education to inmates, implementation of
policies and procedures to decrease the
likelihood of sharps injuries, and operation
of an effective post-exposure management
program.  
Safer sharps devices that have built-in fea-
tures such as sheathing devices, blunted
surgical needles, and retractable needles
and blades are available. These devices
have been shown to significantly reduce
exposure to blood borne pathogens by
decreasing the incidence of accidental
needlesticks. Additionally, many injuries
can be avoided by decreasing the use of
needles (needleless intravenous connec-
tors, using oral medications instead of
injectables, consolidating diagnostic blood
draws, and using urine or oral fluid tests
instead of blood tests).   
Many of the currently available safety
syringes utilize a spring-loaded system. All
safety syringes can be disassembled with
minimal effort, and the springs in some of
them are made of sturdy gauge wire that
may pose security concerns.  
Post-Exposure Prophylaxis
For an excellent review of this topic, the
reader is referred to the following
resources:
HEPP Report July/Aug. 2003: Hepatitis B,
C, and HIV Post-exposure Prophylaxis in
Correctional Settings. Available at
www.hivcorrections.org/
archives/julyaug03/mainarticle.html
MMWR Vol 50, No RR11; 1   06/29/2001:
Updated U.S. Public Health Service
Guidelines for the Management of
Occupational Exposures to HBV, HCV, and
HIV and Recommendations for
Postexposure Prophylaxis
Isolation Concepts
Standard Precautions
Standard precautions merge essential
components from both universal precau-
tions and body substance isolation, and are
to be used for all patients. 
Transmission-Based Precautions 
In addition to utilizing standard precautions
for all patient contacts, transmission-based
precautions are to be used in situations in
which patients are known or suspected to
have a particular CD. There are three cate-
gories of transmission-based precautions,
airborne, droplet and contact, and each
relates to a method of transmission.
Airborne precautions
Airborne precautions are intended to
decrease the likelihood of transmission of
organisms that can be carried in small
sized (less than 5 µm) dust particles or
droplet nuclei and should be used for
patients who are known or suspected to be
infected with Mycobacterium tuberculosis
(MTB), measles, chicken pox (VZV), and
disseminated shingles (VZV). Airborne pre-
cautions require isolation in a private room
that has negative pressure relative to the
hallway and at least six air exchanges per
hour. The air from the room should either
be vented directly to the outside or passed
through a high efficiency filter prior to being
recirculated. The door to the room should
remain closed at all times. While in use, the
room should be evaluated each day to
ensure that it maintains negative pressure
relative to the corridor. All those who enter
the room must wear a respirator that meets
the National Institute for Occupational
Safety and Health's (NIOSH) N-95 stan-
dard, with an ability to filter 1 µm particles
with an efficiency of at least 95%.
Movement of the inmate/patient from the
isolation room should be minimized. While
out of the room, the patient must wear a
surgical mask. 
Droplet precautions
Droplet precautions are intended to
decrease the likelihood of transmission of
organisms that can be carried in particles
that are larger than 5 µm. Droplets of this
size can be created when a person talks,
coughs, sings, or sneezes. Procedures
such as suctioning and bronchoscopy can
also create droplets of this size. These larg-
er droplets do not remain suspended in the
air and usually will travel no more than
three feet. Examples of illnesses that
require droplet precautions include menin-
gitis and epiglottitis caused by
Haemophilus influenza, and infections
caused by N. Meningitidis, influenza, and
Mycoplasma pneumonia. Patients con-
firmed or suspected to have these condi-
tions should be placed in a single cell or
cohorted with other inmates who are infect-
ed with the same organism.  Negative pres-
sure respiratory isolation is not required.
Staff should wear a mask when they are
within three feet of the infected person. If
the inmate/patient must leave the room,
s/he should wear a mask. 
Contact precautions
Contact precautions should be used for
persons known or suspected to be infected
or colonized with organisms that common-
ly cause disease and can be transmitted by
direct or indirect contact. These organisms
can be acquired by direct contact with an
infected or colonized person or indirectly by
contact with inanimate objects. Examples
include Clostridium difficile, Herpes
simplex virus, Hepatitis A virus, VZV,
staphylococci including methicillin-resistant
Staphylococcus aureus, vancomycin-resis-
tant Enterococcus, lice, and scabies.   
Staff should wear gloves when entering the
patient's room, and remove gloves and
wash their hands when leaving. Gowns
should be worn while in the patient's room
and removed prior to leaving. Face shields
and eye protection should be worn during
procedures that are likely to cause splash-
es of body fluids.  Patient care items should
remain in the room and not be reused on
other patients unless they are disinfected.    
CULINARY SERVICES AND
FOOD HANDLERS
All persons being considered for a position
in the culinary department should be
screened for health conditions that would
preclude them from working in food ser-
vices. Potential workers should be exclud-
ed if they have open sores on their hands
or arms, an active respiratory infection, or
an illness characterized by vomiting or diar-
rhea. Those who have had recent positive
cultures for enteric pathogens should not
be approved for food handling until cleared
by infection control. Individuals with poorly
controlled mental illness and those who
lack the intellectual ability to adhere to
appropriate standards of hygiene should
not be utilized as culinary workers. HIV,
hepatitis B, and hepatitis C are not trans-
mitted through food, and the presence of
these infections should NOT preclude oth-
erwise qualified individuals from working in
food services. 
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3Prior to beginning work in culinary services,
all staff should receive an orientation con-
cerning the importance of good hygiene.
Comprehension of basic cleanliness and
disease prevention concepts should be
assured through testing. This education
should be repeated at least annually.
Supervisors should perform daily inspec-
tions of workers to ensure that they do not
have active respiratory illnesses, open
sores on their hands or arms, or an active
gastrointestinal illness. Those who are ill
should be removed from food services until
cleared by infection control. 
Laundry
Insufficient access to clean clothes and
linen is associated with acquisition of
body lice and methicillin-resistant
Staphylococcus aureus among those
housed in congregate living environments. 
In the correctional environment, there are
legitimate custody concerns regarding
laundry distribution. Clothing and linen are
often hoarded, and can be cut up to make
non-approved clothing, curtains, and
escape items such as ropes and altered
clothing. These concerns notwithstanding,
inmates should be provided an adequate
supply of clothing and linens, and these
items should be exchanged on a frequent
and regular basis.  
Those who handle contaminated laundry
should be provided gloves, gowns, masks,
and face shields for use while handling and
sorting contaminated laundry. Thick utility
gloves may provide workers with additional
protection, and can be decontaminated and
reused if they are not cracked, torn, or
punctured.  
Dirty linens should be rolled up to confine
solid waste and to avoid aerosolization of
organisms. Soiled linen should be bagged
or put into carts at the location where it was
used, and should not be sorted or other-
wise excessively handled in any patient-
care area. Linen from inmates who are on
contact precautions should be handled
according to published guidelines. Linen
that has been contaminated with blood or
other potentially contagious body fluids
should be either placed in leak proof bags
or containers labeled with the biohazard
symbol, or placed in red bags for trans-
portation. Because of the potential for dis-
ease transmission during handling of laun-
dry, the sorting process should be mini-
mized. Adequate ventilation should be
maintained in the laundry area to decrease
the potential for transmission of airborne
diseases. 
To minimize sharps being disposed of in the
laundry stream, staff should be educated to
adhere to procedures that detail the appro-
priate disposal of sharps, and laundry work-
ers should be trained on how to handle
sharps that are found in laundry. Needle
containers should be readily available in
laundry areas.  
A temperature of at least 71o C (160o F) for
a minimum of twenty-five minutes has com-
monly been recommended to effectively kill
microorganisms. Studies have demonstrat-
ed that low temperature washing at 22-50o
C can effectively reduce microorganism
concentrations when adequate amounts of
chlorine bleach are utilized. 
Barbering
In most jails and prisons, inmates perform
the majority of haircuts. In many cases,
these inmate barbers have had little or no
training. Barbering tools may be reused
without appropriate disinfection, creating an
opportunity for the transmission of bacteri-
al, fungal, or parasitic organisms. All
inmates who are to serve as barbers should
receive training, undergo post-education
testing, and be observed periodically to
ensure adherence with infection control
practices. Access to necessary disinfection
supplies should be facilitated. 
Barbers should be provided containers to
hold soiled linens. Towels should only be
used on one client before being appropri-
ately laundered. Containers should also be
provided for the disinfection of combs,
brushes, clippers, and scissors. An ade-
quate supply of a disinfectant solution
should be provided to allow for the com-
plete immersion of barbering tools between
haircuts. 
Before each use, all non-electrical instru-
ments should be cleaned with soap and
water and then soaked in a disinfectant with
known activity against bacteria, viruses,
nd fungi. This solution should be changed
whenever visibly dirty, but at least weekly.
Before each use, clippers and other electri-
cal instruments should be brushed to
remove all foreign matter and then disin-
fected by wiping with a disinfectant.
Disinfected instruments should be stored in
a clean, covered area.
All those who perform barbering activities
should thoroughly wash their hands with
soap and water and/or an approved hand
disinfectant before each client. Barbers
who are infected with an organism that is
readily transmitted to others during barber-
ing activities should not work until they are
no longer contagious.  Examples of condi-
tions that can be transmitted during haircut-
ting include purulent conjunctivitis (pink
eye), VZV, respiratory illnesses such as
colds, influenza, and tuberculosis, bacterial
skin infection such as impetigo or cuta-
neous abcesses, methicillin-resistant
staphylococcus infection, and ectopara-
sites such as scabies and lice.  Hepatitis B,
Hepatitis C, and HIV are not transmitted
during routine barbering activities and
should NOT preclude employment as a
barber.
General infection control resources
w The Occupational Safety and Health
Organization (OSHA) is part of the United
States Department of Labor, and exists to
develop and enforce workplace safety
standards.  www.osha.gov
w The Centers for Disease Control (CDC)
is an advisory body of the federal govern-
ment. The CDC creates guidelines and
provides recommendations concerning
health-related issues.  www.cdc.gov
w The National Institute for Occupational
Safety and Health (NIOSH) is part of the
CDC. www.cdc.gov/niosh/homepage.html
w The Joint Commission on Accreditation
of Healthcare Organizations (JCAHO) pub-
lishes performance standards and pro-
vides certification to health care organiza-
tions that meet them.  www.jcaho.org
w The Association for Professionals in
Infection Control and Epidemiology (APIC)
is a professional organization for those
involved in Infection Control.  APIC collab-
orates with the CDC to publish infection
control guidelines, conducts research,
sponsors educational programs, and pro-
vides resource materials. www.apic.org
w Herwaldt LA, ed. A Practical Handbook
for Hospital Epidemiology. Thorofare, NJ:
SlACK Incorporated 1998
w Mayhall CG, ed. Infection Control and
Hospital Epidemiology. Baltimore,
Maryland: Williams and Wilkins; 1999
w MRSA information:
http://www.cdc.gov/ncidod/hip/aresist/mrsa
.htm,  Methicillin-Resistant Staphylococcus
Aureus Skin or Soft Tissue Infections in a
State Prison-Mississippi, 2000. MMWR
2001;50:919-22,  Outbreaks of
Community-Associated Methicillin-
Resistant Staphylococcus Aureus Skin
Infections-Los Angeles County, California,
2002--2003. MMWR 2003;52:88.,
Methicillin-Resistant Staphylocccus Aureus
Infections in Correctional Facilities-
Georgia, California, and Texas, 2001-
2003.MMWR 2003; 52(992-996) 
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Dear Correctional Colleagues:
A formidable challenge in correctional health, infection control is perhaps one of the mo t
effective ways we can benefit our communities. Most of our patients have had inadequate
health care before incarceration, which, combined with life patterns of risk-taking that have
brought them to jail or prison, results in significantly higher rates of conditions of public
health significance, particularly infections. 
Incarceration, however, presents us with several opportunities: we are able to find our
patients, our inmates have the time to attend to their treatment, and there is a source of
payment for their care. Thus, we should be able not only to minimize transmission of dis-
ease within jail or prison, but also to release people back into the community who are in
better health than before their incarceration.
The key to infection control is education of all staff. Correctional officers are not expected to
know everything about a given disease. Yet, they should know what signs and symptoms
should lead them to ensure that an inmate gets to health services. They should also know
enough to avoid or prevent dangerous practices and when they do NOT have to be con-
cerned about a particular health-related issue.
Health care staff must have a high index of suspicion for communicable diseases and they
should know how to stop transmission. Successful disease prevention interventions must fit
the culture in which they are implemented. For example, control of drug supplies in correc-
tions is much more feasible than in the general public. Needle exchange programs, on the
other hand, may not be. Acceptable interventions require joint support by both health ser-
vices and security.
Infection control in corrections is very possible. With careful attention to infection control it is
possible, for instance, even in prisons with congregate living, to lower tuberculosis disease
rates to those seen in the outside community. 
Sincerely,
Lester Wright, MD
Letter from the Editor
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5Staphylococcus aureus (SA) is a bacterium commonly found on the
skin or anterior nares in the nose of healthy individuals. Although SA
often colonizes humans without causing disease, it can be responsi-
ble for minor to life-threatening infections of the skin, bone, blood,
heart valves, and lungs. SA is easily spread by contact with the skin
of a person infected or colonized with the bacteria. SA can also be
acquired from the hands of health care workers or inanimate objects
that have been in contact with a person carrying the organism.  
Nursing homes and other long-term care facilities have been identi-
fied as reservoirs of MRSA. Over the past decade, MRSA has also
emerged as a cause of skin and soft tissue infections in the commu-
nity. Most MRSA infections are minor infections of the skin that take
the form of pustules, furuncles or boils. Generally, these conditions
are mild, self-limited, and do not require aggressive treatment. Not
surprisingly, this organism is now being increasingly recognized as a
cause of infections in residents of jails and prisons. In the correc-
tional setting, staphylococcal skin lesions have often been mistak-
enly attributed to spider bites. In reality, spiders rarely bite people,
and most of the bites are inconsequential.
Once community-associated methicillin-resistant SA (CA-MRSA)
has a foothold in a correctional facility, it is likely to remain there
indefinitely. For every identified colonized or infected inmate or staff
member, there are many who are not identified. Control of outbreaks
relies upon reducing the bacterial load in a facility by treating identi-
fied cases, decreasing the likelihood of bacteria being passed
between individuals, and decreasing the size of the inoculum when
bacteria are transmitted.  
Penicillin resistance in SA is due to the production of beta lacta-
mase, an enzyme that breaks down penicillin's beta lactam ring and
renders the drug inactive. Within a few years of the first clinical use
of penicillin in the 1940s, resistance due to beta lactamases was
identified. Within a year of the introduction of the semisynthetic, beta
lactamase-stable, penicillin methicillin in 1960, MRSA strains were
identified. By the 1990s, over half of SA isolated in some hospitals
were MRSA.  
Methicillin resistant strains are resistant to all beta lactam antibiotics,
including penicillins and cephalosporins. In addition, MRSA strains
often carry plasmids that lead to resistance to aminoglycosides, flu-
oroquinolones, macrolides, and chloramphenicol. Many MRSA
strains are susceptible to trimethoprim-sulfamethoxazole, clin-
damycin, and rifampin. Virtually all SA are fully susceptible to van-
comycin. However, the first clinical isolate of SA with reduced sus-
ceptibility to vancomycin was reported from Japan in 1996. The first
documented case of infection caused by vancomycin-resistant S.
aureus (VRSA) (vancomycin MIC >32 µg/mL) in a patient in the
United States was reported in 2002. 
Even though SA infection may be suspected, cultures and sensitivi-
ties are required to confirm the diagnosis of MRSA. Empirical treat-
ment can be based upon the antibiotic susceptibility pattern of
organisms circulating within the facility.  Cultures should be obtained
even during outbreaks. Cultures should also be obtained if a patient
fails to respond to treatment. The infection control officer or the infec-
tion control committee should review patient records for appropriate-
ness of diagnosis and treatment.
Treatment
The indiscriminate use of antibiotics can lead to increased drug
resistance and should be discouraged. In many cases, drainage and
appropriate wound care will suffice.  If used, antibiotics should be
selected that are known to be effective against MRSA.
Trimethoprim-sulfamethoxazole (Bactrim, Septra) in a dose of one
double-strength tablet twice daily is usually effective in patients who
have MRSA. Some clinicians also add rifampin in a dose of 600 mg
once daily. Due to the rapid development of resistance, rifampin
should not usually be used alone to treat infections due to SA. For
mor  serious infections, vancomycin, linezolid, daptomycin, and
quinupristin-dalfopristin may be used.
Vancomycin has been used for many years for the treatment of SA
and MRSA. Concerns about vancomycin include hypersensitivity
reactions, a histamine release syndrome (red man syndrome) relat-
ed to rapid infusion, lack of availability of an oral formulation for the
reatment of systemic infection, concerns about the development of
vancomycin resistant enterococcus, and concerns about the emer-
gence of vancomycin resistant staphylococcus aureus (VRSA) and
strains with reduced sensitivity to vancomycin (VISA).  
Eradication of Carriage
SA and MRSA are commonly found in the anterior nares of other-
wise healthy asymptomatic individuals. Routine eradication of this
carriage is neither efficacious nor recommended. In some cases of
recurrent active disease, clearance of the organism from the nose
can be beneficial. Mupirocin calcium 2% ointment (Bactroban)
applied to both anterior nares bid for 5-7 days, is commonly used for
this purpose.
Infection Control Measures
Once CA-MRSA infections are identified, personnel at all levels and
in all disciplines in the facility need to be informed and to participate
in control measures. Factors that may have contributed to outbreaks
of MRSA in jails and prisons in the U.S. include poor hygiene,
restricted access to medical care, uninformed medical staff, and fail-
ure to diagnose MRSA infections because of infrequent culture col-
lection.  Risk factors for MRSA that have been identified in jails and
prisons have included skin lacerations, prolonged incarceration, pre-
vious antimicrobial use, self-draining of boils, performing one's own
dres ing changes, washing clothes by hand, sharing clothing or
linen, and sharing soap. 
Hygiene can be improved by patient education, improving access to
soap and bathing, maintaining an adequate supply of dressing mate-
rials, and following appropriate laundry procedures. Materials com-
ing into the laundry may be contaminated with CA-MRSA. Laundry
workers must be provided with protective equipment and instructed
regarding its use. CA-MRSA has the potential to produce toxins and
ca e food-poisoning, so special care should be exercised in carry-
ing on "routine" daily review of workers for infections at the time of
an outbreak. Access to medical care can be improved by eliminating
co-payment requirement for contagious conditions, maintaining suf-
ficient clinical staff to ensure prompt access to care, and establish-
ing 24/7 urgent care for serious medical conditions.  All correctional
employees should be educated about the importance of prompt
evaluation and treatment of infectious conditions.  Furthermore, clin-
icians should be reminded to culture all skin and soft tissue infec-
tions and to not attribute skin lesions to insect bites.  
CA-MRSA survives well on particularly warm, moist surfaces. Proper
cle ning techniques, which should be reviewed with team supervi-
sors, reduce the bacterial load, especially when antimicrobial clean-
ing agents (most often those containing quaternary ammonium com-
pounds) are used. Facilities with CA-MRSA outbreaks should estab-
lish cleaning schedules and log their cleaning activities as part of
their overall facility quality improvement activities. 
A physical review of all units can therefore be very helpful in reduc-
Dean Rieger* MD, MPH, Medical Director, Indiana Department of Corrections
Joseph Bick** MD, Chief Medical Officer, California Medical Facility
Spotlight: So Your Facility Has CA-MRSA 
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6ing opportunities for bacterial transfer. Surfaces that become easily
contaminated require special attention, such as toilet seats, sinks,
bathtubs, weight room equipment, etc. that are often in direct con-
tact with skin. Frequent use of antimicrobial products can leave a
residual film that can reduce the surface load of bacteria over an
extended period of time. Hand washing is the most effective way to
reduce transmission of CA-MRSA. The practice of leaving a towel
next to a sink should be avoided, as shared towels provide perhaps
the best transfer medium of all for CA-MRSA. Paper towels should
be used instead.
Terminal disinfection should be employed in housing areas and is
especially important during CA-MRSA outbreaks. Materials that
cannot be sanitized should be discarded.  Except for patients with
secretions that cannot be controlled and are likely to contaminate
the environment (including prisoners who intentionally spread cont-
amination), no special separate housing is necessary. 
If inmates understand how CA-MRSA is transmitted, they are more
likely to practice good hygiene and protect themselves from trans-
mission. Inmates should be educated about personal hygiene and
advised to avoid touching other individuals' wounds or wound
drainage. Inmates should be provided regular access to soap, show-
ers, and sinks. Clinical staff should follow standard precautions
while providing wound care. Infection control measures can never
be overemphasized; even in the hospital setting many healthcare
professionals neglect hand washing. In an effort to improve hand
hygiene, the use of alcohol-containing antiseptic scrubs is increas-
ingly being encouraged. However, security concerns may lead to
these particular disinfectants not being universally embraced in the
correctional setting. During outbreaks prisoners need to be encour-
aged to present possible CA-MRSA lesions to health services per-
sonnel for examination. Barriers to health care should be reviewed
and lowered or eliminated during outbreaks. For example, during a
CA-MRSA outbreak a facility could waive co-payment for evaluation
of skin problems.
Conclusion
An aggressive approach to the management of MRSA can be effec-
tive. In Indiana, one moderately large facility was reporting approxi-
mately 40 cases of CA-MRSA per month when basic outbreak mea-
sures were implemented; within six weeks the outbreak was termi-
nated. In another facility, a maximum-security setting, an alert physi-
cian noted an association between infections and new tattoos. The
facility was briefly locked down and searched. With confiscation of
the contaminated tattoo works, the outbreak was terminated. A par-
ticularly severe outbreak occurred in one Indiana jail. It was discov-
ered that inmates were self-inoculating in order to get a ride out of
the facility to a hospital. The high-load inoculation resulted in very
aggressive infections and one prisoner nearly died. In other correc-
tional settings, intensive efforts to control MRSA have not been as
effective. 
The involvement of experts in infection control and infectious dis-
e ses can be useful in both managing individual patients and estab-
lishing protocols specific to the unique needs of each facility.
C rrectional facilities experiencing outbreaks of MRSA should seek
assi tance from their local and state health departments. MRSA out-
breaks can be reported to CDC (TEL: 800-893-0485) through state
departments of corrections and state health departments.
Preventing MRSA disease in inmates might be an important mea-
sure for preventing MRSA in the community outside the correction-
l facility. 
Disclosures: 
*Nothing to disclose
**Nothing to disclose
Spotlight... (continued from page 5)
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HIV 101: Essential Elements of Standard Precautions in the Correctional Setting
Hand washing
Personal Protective 
Equipment (PPE)
w Gloves, standard disposable 
w Gloves, thick utility or 
gloves with wire mesh
w Masks & respirators
w Gowns
w Face shields, goggles
Sharps (lancets, needles,
syringes, scalpels, tattoo
equipment, razor blades, 
stabbing instruments, etc.)  
Housing
Laundry
Housekeeping
Hands should be washed after touching any body fluids, after removing gloves, and between patient
contacts. 
PPE should be readily accessible in all patient care areas, housing units, transportation vehicles, the
laundry, and anywhere that staff are likely to come into contact with inmate/patients. 
To prevent contact with blood, body fluid, mucous membranes, nonintact skin, and contaminated
items.
To protect staff from sharps injury during the performance of clothed body searches and housing
searches.
To protect mucous membranes of the mouth from splashes or sprays of blood and body fluids, and to
avoid inhalation of airborne diseases.
To protect skin and clothing from intentional or accidental splashes or sprays of blood and other body
fluids.
To protect mucous membranes of the mouth, eyes, and nose from intentional or accidental splashes
or sprays of blood and other body fluids.
Used sharps should always be placed immediately in puncture resistant containers. Sharps should not
be passed from person to person. Sharps containers should be available in all areas where sharps
are used. Those who conduct body searches and housing searches should be taught techniques to
avoid being injured by hidden sharps. Tongs to pick up sharps and mirrors to visualize hidden areas
can be used during searches. Pocket-sized puncture-proof evidence containers can be used to carry
sharps discovered during searches.  
Inmate/patients who cannot or will not maintain appropriate hygiene should be placed in single cell
housing. 
Treat all laundry as if it is contaminated; prevent contact with skin and mucous membranes. Use PPE. 
Procedures for cleaning and disinfection of equipment, furniture, and the environment should incorpo-
rate the use of PPE and techniques to minimize the transfer of microorganisms
7Ask the Expert: Skin/Soft Tissue Infection in a Patient with HIV
Bethany Weaver*, D.O., M.P.H., Acting Instructor of Medicine, University of Washington Center for AIDS & STD Research (CFAR) and Northwest
Correctional Medicine Education Program.
CASE:  A 49 year-old inmate presents on sick call with concerns about a pimple on her sacral area that has been problematic for three
weeks. She has been incarcerated for one year. She has untreated asymptomatic HIV infection with a recent CD4 count of 233 and a HIV-
1 viral load of 174,000 copies/mL. She says that "she popped it (the pimple)," and though it appeared to improve initially, "it came back
again". She also has two similar areas on her left hand and left inner thigh. She denies fevers, chills, nausea/vomiting, headache, myal-
gias/arthralgias, fatigue, cough/dyspnea. She has been feeling depressed recently and has not been bathing regularly. She has a history of
cocaine dependence but denies injection drug use. She takes acyclovir regularly for genital HSV suppression but is on no other medica-
tions.  
Physical exam is notable for BP 120/67, pulse 75, respirations 14, temperature 37.5° C, and weight 130 lbs. She appears disheveled and
has poor dentition. She has a supple neck with full range of motion and no palpable lymphadenopathy. Her chest is clear to auscultation,
and her cardiac exam reveals a regular rate and rhythm, normal S1 and S2, and no cardiac murmurs, rubs, or gallops. Her abdomen is soft,
nontender with normoactive bowel sounds and no hepatosplenomegaly. Her extremities show no cyanosis, clubbing or edema. Skin exam-
ination is notable for two small 2.5 cm abscesses on the dorsum of her left hand and two similar areas on the left inner thigh. She has a 6
x 8 cm sacral abscess, with erythema surrounding induration and some oozing of thick yellow fluid. There are no vesicular lesions. Her neu-
rological exam is nonfocal.
Q:  What tests should you perform/order, if any?
A: A bacterial culture of the oozing fluid from the sacral abscess would
be helpful since this is a new visit for this inmate with a new skin/soft
tissue infection. This infection could be due to a variety of organisms,
including community-acquired methicillin-resistant Staphylococcus
aureus (MRSA). The susceptibility pattern for this organism had not
been well established at the facility where she is incarcerated. If the
patient appeared systemically ill with fever, chills, chest pain, cough,
dyspnea, abdominal pain, nausea, vomiting, or weight loss, then bac-
terial blood cultures, a complete blood count, and a chest x-ray should
also be obtained. One could also consider performing a PPD if any
question of tuberculosis is considered.   
A culture is performed, and yields two colonies of coagulase positive
Staphylococcus (S. aureus). The organism is methicillin-resistant by
PBP2A latex test, which indicates resistance to penicillins,
cephalosporins, beta lactam/beta lactamase inhibitor combinations,
imipenem and other beta lactams. The organism is reported as sensi-
tive to Clindamycin, Gentamicin, Levofloxacin, Trimeth_sulfamethoxa-
zole, and Vancomycin.
Q:  What treatment(s) should you offer this inmate?
A: There are two important treatments to consider: antibiotics and sur-
gical debridement. In general, empiric oral antimicrobial therapy to
cover common skin/soft tissue organisms, such as Streptococcus and
Staphylococcus, including MRSA, should be given pending final cul-
ture results or based on a known antibiogram within the institution,
indicating known resistance patterns for MRSA. Antibiotics are not
always needed if the infection is localized and good wound care is
available.  In this patient with advanced HIV disease, multiple abscess-
es, and a history of not adequately caring for herself, it is prudent to
offer oral antimicrobial therapy.  Once the isolate's final susceptibility
pattern is known, therapy can be tailored. Unlike hospital-acquired
MRSA strains, which are usually resistant to multiple antibiotics, com-
munity-acquired (CA) MRSA strains are often resistant only to beta-
lactam antibiotics. Thus, the empiric regimen might include agents
such as trimethoprim/sulfamethoxazole, doxycycline, or clindamycin,
with or without rifampin. Rifampin monotherapy is NOT recommended,
as resistance to this agent can evolve rapidly. Ideally, empiric therapy
should be based on institutional resistance patterns for MRSA, if
known.  In the setting of an MRSA outbreak within a facility, all cases
do not require a culture, if the outbreak is well defined with a known
established susceptibility pattern for the etiologic isolate. The addition
of rifampin for improved clinical response is often reserved for patients
with recurrent infections or serious infections in which bone, blood,
hardware, and/or deep tissue (i.e. fasciitis) is involved. Surgical
debridement is usually reserved for deep infections and/or infections
with associated fluctuance that are not draining adequately. Although
this inmate had a fairly large sacral abscess, it was open and draining
well without areas of fluctuance or devitalized tissue. Therefore, no
surgical debridement was required.  Depending on the sophistication
of the facility, this patient could be managed with outpatient care with
wound dressing changes and monitoring of medication in the
prison/jail clinic at regular intervals, as opposed to referral to an out-
patient care clinic at a local hospital or to an infectious disease clinic
in  community.  Whether or not the inmate took her medications on
pill line as opposed to "keeping on person" is an individual decision
that should be made by the provider, keeping the extent of disease, the
compliance of the inmate, and the level of understanding of the prob-
lem by the inmate in mind.  One last point is that this inmate should be
re-examined after the lesions have cleared to be sure a cyst (e.g.
pilonidal) was not missed and predisposed her to this infection.
Q:  What infection-control measures, if any, should you recom-
mend?
A: Personal hygiene and environmental sanitation practices are criti-
cal.  Wound dressings must be performed with strict attention to con-
tact precautions. Frequent hand washing, daily bathing, and proper
towel hygiene should be emphasized as discussed in detail in the
spotlight on MRSA article in this issue of HEPP Report.  If inmates and
staff understand how CA-MRSA is transmitted, then infection control
efforts are more likely to be successful.  
Cli ical Follow-up
The inmate was treated empirically with trimethoprim/sulfamethoxa-
zole (160-800) bid for 14 days with daily wound packing with sterile
gauze and wet to dry dressing changes. The areas dried up com-
pletely within a period of 3 weeks, and she suffered no complications.  
Concluding Remarks
CA-MRSA outbreaks continue to increase.  Recent evidence suggests
that this organism contains the Panton Valentine leukocidin gene,
which codes for the production of cytotoxins that cause tissue necro-
sis and leukocyte destruction leading to skin and soft tissue infections
or necrotizing pneumonia.  Because no systematic, population-based
surveillance of CA-MRSA isolates exists, the true prevalence is not
known.  Based on previous experience with penicillin-resistant strains,
experts estimate that up to 25% of CA-SA may be MRSA within the
next five to 10 years. Patients with CA-MRSA infections are at risk for
life-threatening infections, particularly if a beta-lactam antibiotic is
used and the infecting strain proves to be resistant. Judicious use of
antibiotics, including consideration of institutional or individual resis-
tance patterns in choosing the appropriate treatment, is very important
in managing CA-MRSA infections. Use of agents such as linezolid and
vancomycin should be reserved for more serious infections, such as
bacteremia, endocarditis, and acute osteomyelitis.  
Disclosures:
*Pfizer: Stockholder
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Centerforce 5th Annual
Inside/Out Summit 
September 11 - 15, 2004 
San Francisco Airport Marriott,
Burlingame, CA
Call: Beth Houghton 
415.456.9980 x124
Visit: www.centerforce.org/
summit
Infectious Disease Society of
America
September 30 - October 3, 2004
Boston, MA
Visit: www.idsociety.org
ProVisions IX, the Northeast
Multicultural Conference on
HIV/AIDS
October 13 - 15, 2004
New Haven, CT
Call: Carla Giles, Program
Committee Co-Chair
203.688.3184
Email: Carla.Giles@ynhh.org or
Leif.Mitchell@yale.edu.
Visit: www.provisionsct.org
Management of HIV/AIDS in
the Correctional Setting: A
Live Satellite
Videoconference Series
"Early Identification of HIV &
Newer Testing Strategies"
October 19, 2004
12:30-3:30 p.m. EST
Call: 518.262.4674
E-mail: ybarraj@mail.amc.edu
Visit: www.amc.edu/patient/
hiv/hivconf/index.htm
44th Annual ICAAC
October 30 - November 2, 2004
Washington, DC
Call: 800.974.3621
Visit: www.asm.org
National Conference on
Correctional Health Care
November 13 - 17, 2004
New Orleans, LA
Call: 773.880.1460
Visit: www.ncchc.org
Save the 
Dates
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Dr. Stephen Tabet 1961 - 2004
It is with great sorrow that we mourn the passing of a former HEPP Report Deputy Editor, an AIDS
activist, a fellow physician, a colleague, and dear friend, Dr. Stephen Tabet, who died unexpected-
ly at his home on July 6 at age 42. Tabet, an associate professor of medicine at the University of
Washington, physician at Harborview Medical Center's Madison Clinic, an educator at the
Northwest AIDS Education Training Center, and researcher at the HIV Vaccine Trials Network, was
a valued member of HEPP Report's editorial board for over five years, during which he authored
countless case studies on the management of infectious diseases in the correctional setting. 
Dr. Tabet spent much of the last decade of his life working to educate others about the care of HIV-
infected individuals. He had a special interest and passion for caring for those with HIV in the cor-
rectional setting. It was because of his dedication and hard work that he was able to change the
delivery of healthcare at several correctional institutions in Washington state. Those who worked
with him in this cause were touched by his gentle spirit, empowered by his compassion and knowl-
edge, and will be forever indebted to him for the impact he made on their lives and on the lives of
their patients.
In perhaps one of his most significant contributions to those living with HIV, Tabet played a vital role
as an expert witness in the Leatherwood v. Campbell case in which HIV-infected inmates at the
Limestone Correctional Facility in Alabama filed a federal suit against prison officials concerning
medical care. Tabet reviewed innumerable medical records, examined inmates, and finally issued
a comprehensive 125-page report on the state of HIV care at the Limestone Facility. Thirty-eight
HIV-infected inmates died at Limestone prior to Dr. Tabet's report; Tabet reviewed every death in
detail. 
His findings elicited a nationwide response from legislators, healthcare providers, and advocates.
Alabama settled the suit May 27, 2004, and Alabama prison officials have agreed to improve sub-
stantially the medical care and treatment of Alabama's HIV-infected inmate population. Indeed, Dr.
Tabet's contribution has set a precedent for correctional HIV healthcare in the United States and
has served as a beacon of hope for prison healthcare advocates.
Unbeknownst to Dr. Tabet, HEPP Report had nominated him to receive the Canadian HIV/AIDS
Legal Network's Award for Action on HIV/AIDS and Human Rights for his selfless commitment to
the HIV-infected patients at Limestone. We at HEPP Report know of few individuals who have
given so much to improve the care of HIV-infected persons living inside and outside prisons. We
plan to commemorate his life and work by awarding the first annual Steven Tabet Prison Medicine
Advocacy Award to a deserving individual at the next NCCHC meeting in October 2004. All those
who had the privilege of working with Dr. Tabet, and especially those who knew and loved him, will
sorely miss him. The staff at HEPP Report would like to honor the memory of Dr. Tabet by contin-
uing his vision of improving correctional healthcare.  
- Joe Bick, Annie De Groot, Beth Weaver, Julia Noguchi, and the members of the HEPP Report
editorial board. 
In Memoriam
Resources
For a copy of Dr. Steven Tabet's report on the conditions of HIV infected prisoners at the
Limestone facility, visit:
www.schr.org/prisonsjails/press%20releases/limestone_report.8-26-03_web.doc
Details of his personal examination of numerous HIV infected prisoners, pleadings and 
photographs of the prison can be viewed on the website of the Southern Center for Human
Rights at: 
www.schr.org/prisonsjails/press%20releases/press_limestonereport.htm
OR
www.schr.org/prisonsjails/press%20releases/Limestone_Complaint-Amended.(1).rtf
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Self-Assessment Test for Continuing Medical Education Credit
Brown Medical School designates this educational activity for 1 hour in category 1 credit toward the AMA Physician’s Recognition Award.
To be eligible for CME credit, answer the questions below by circling the letter next to the correct answer to each of the questions. 
A minimum of 70% of the questions must be answered correctly. This activity is eligible for CME credit through January 31, 2005. 
The estimated time for completion of this activity is one hour and there is no fee for participation.
1. The primary functions of a jail or prison infection control 
committee are to:
a) ensure that infection control policies are the same as 
other facilities of the same security level in that state
b) minimize patient/inmate and employee risk
c) ensure that there is an active, effective, institution-wide 
infection control program that develops effective measures to 
prevent, identify, and control infections that occur in the 
institution
d) a and b 
e) b and c
2. Airborne precautions should be used for patients who are
known or suspected to be infected with:
a) Mycoplasma pneumonia
b) Methicillin resistant staphylococcus aureus (MRSA)
c) Varicella
d) Heamophilus influenza meningitis
e) None of the above
3. A condition that should not preclude an inmate from working in
culinary services is:
a) poorly controlled mental illness
b) upper respiratory infection
c) vomiting or diarrhea
d) chronic Hepatitis B
e) open sores on their hands and arms
4. Patients with wound secretions that cannot be controlled or
those who intentionally spread contamination should be placed in
separate housing. True or False?
a) True
b) False
5. Many MRSA strains are susceptible to:
a) Trimethoprim-sulfamethoxazole, clindamycin, and rifampin
b) penecillins
c) cephalosporins
d) None of the above
6. Within the next decade, experts estimate that the prevalence
of CA-MRSA may be as high as:
a) 10%
b) 25%
c) 30%
d) 35%
BROWN MEDICAL SCHOOL •  OFFICE OF CONTINUING MEDICAL EDUCATION •  BOX G-A2  •  PROVIDENCE, RI 02912
The Brown Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME)to provide continuing medical 
education activities for physicians.  
The use of the Brown Medical School name implies review of the educational format and material only.  The opinions, recommendations 
and editorial positions expressed by those whose input is included in this bulletin are their own.  They do not represent or speak for the 
Brown Medical School.
For Continuing Medical Education credit please complete the following and mail or fax to 401.863.2660 or 
register online at www.hivcorrections.org. Be sure to print clearly so that we have the correct information for you.
Name __________________________________________________________________ Degree ____________________
Address ____________________________________________________________________________________________
____________________________________________________________________________________________________
City ____________________________________________________ State ________ Zip ________________________
Telephone ________________________________________________ Fax ______________________________________
HEPP Report Evaluation
5 Excellent    4 Very Good    3 Fair    2 Poor    1 Very Poor
1. Please evaluate the following sections with respect to:
educational value clarity
Main Article 5  4  3  2  1   5  4  3  2  1      
Ask the Expert5  4  3  2  1   5  4  3  2  1
Save the 
Dates 5  4  3  2  1   5  4  3  2  1
2. Do you feel that HEPP Report helps you in your work?
Why or why not?
3. What future topics should HEPP Report address?
4. How can HEPPReport be made more useful to you?
5. Do you have specific comments on this issue?
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